Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Truncation in Survival Analysis01:09

Truncation in Survival Analysis

299
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
299
Censoring Survival Data01:09

Censoring Survival Data

228
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
228
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

258
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
258
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

280
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
280
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

394
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
394
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

196
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
196

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention.

International urology and nephrology·2014
Same author

Simple whole-cell biodetection and bioremediation of heavy metals based on an engineered lead-specific operon.

Environmental science & technology·2014
Same author

The dual PI3K/mTOR inhibitor NVP-BEZ235 prevents epithelial-mesenchymal transition induced by hypoxia and TGF-β1.

European journal of pharmacology·2014
Same author

The genus Anemarrhena Bunge: A review on ethnopharmacology, phytochemistry and pharmacology.

Journal of ethnopharmacology·2014
Same author

Aldehyde dehydrogenase-2 is a host factor required for effective bone marrow mesenchymal stem cell therapy.

Arteriosclerosis, thrombosis, and vascular biology·2014
Same author

Myocardial steatosis and its association with obesity and regional ventricular dysfunction: evaluated by magnetic resonance tagging and 1H spectroscopy in healthy African Americans.

International journal of cardiology·2014

相关实验视频

Updated: Sep 9, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

对左截止右截止竞争风险数据的累积发病率函数的回归建模:修改后的伪观测方法

Rong Rong1, Jing Ning2, Hong Zhu3

  • 1Department of Statistical Science, Southern Methodist University, Dallas, Texas 75275.

Communications in statistics: theory and methods
|September 2, 2025
PubMed
概括

这项研究引入了一种新的伪观察 (PO) 方法,用于分析复杂数据的累积发病率函数 (CIF),改善左截断和右截断的竞争风险的统计建模. 这种方法处理了一般的截断和审查,在医学研究中提供了更广泛的应用.

关键词:
竞争中的风险累积发生率函数取决于截断/审查反向概率权重伪观察

更多相关视频

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

374

相关实验视频

Last Updated: Sep 9, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

374

科学领域:

  • 生物统计学
  • 生存分析
  • 流行病学

背景情况:

  • 现有的累积发病率函数 (CIF) 的统计方法与左截断和右截断的竞争风险数据通常依赖于复杂的方程和独立的审查/截断假设.
  • 伪观测 (PO) 方法已经显示出对右截止数据的CIF回归有希望,但其扩展到左截止数据是有限的.

研究的目的:

  • 扩展伪观测 (PO) 方法用于累积发病率函数 (CIF) 的回归建模,同时存在左截断和右截断.
  • 开发一种适应总体截断和审查机制的方法,包括共变量依赖的场景.

主要方法:

  • 该研究建议使用伪观测 (PO) 来直接建模CIF,用于左截断和右截断的竞争风险数据.
  • 通过将共变量调整的权重纳入CIF的逆概率加权 (IPW) 估计器来解决共变量依赖的截断和审查.
  • 建议的估计器的大样本属性得出,并通过模拟研究评估有限样本的性能.

主要成果:

  • 拟议的伪观测 (PO) 方法有效地模拟了总结和审查条件下的累积发病率函数 (CIF).
  • 反向概率加权 (IPW) 估计器,调整为共变量依赖的截断/审查,在模拟中显示出强大的性能.
  • 该方法已成功应用于真实世界队列研究,涉及孕妇接触氨酸衍生物.

结论:

  • 扩展伪观测 (PO) 方法为分析具有竞争风险的复杂生存数据,左切割和右审查提供了灵活和强大的框架.
  • 这种方法放松了限制性的独立性假设,提高了流行病学和临床研究中的统计推断的可靠性.
  • 这些发现为处理各种科学领域的时间到事件数据的研究人员提供了宝贵的工具.